Department of Dermatology

Julide T. Celebi, M.D.

Associate Professor of Clinical Dermatology

Melanoma is the fifth and seventh most commonly diagnosed cancer in American men and women, respectively. Currently, it is estimated that 1 in 55 men and 1 in 82 women in the US will be diagnosed with melanoma in his or her lifetime. Despite the frequency with which melanoma is encountered, relatively few advances in the treatment of melanoma have been made and the mortality rate continues to rise. Several genes have been implicated in the pathogenesis of melanoma, however its molecular basis is largely unknown. The goal of Dr. Celebi's program is to identify genes that play a role in melanoma development and progression. These studies will not only lead to a molecular classification of melanoma, but will also help to predict clinical outcome and lead to discovery of new targets for therapy.

Board Certified	American Board of Dermatology, 1998
Education	Doctor of Medicine,1990 Istanbul University, Istanbul School of Medicine Istanbul, Turkey
Training	Clinical Research Fellow in Dermatology, 1992-1994 Gerogetown University Washington, DC Resident in Dermatology, 1995-1998 NewYork Presbyterian Hospital, CUMC New York, NY Fellow in Medical Genetics and Cancer Genetics, 1998-2000 Columbia University, Department of Dermatology New York, NY Fellow in Genetics, 2000-2002 Columbia University, Department of Pathology New York, NY
Research Interests	Genetics of Melanoma

Contact Information
Columbia University Skin & Laser Center
51 West 51st Street, Suite 390
New York, NY 10020
Tel: 212.326.8889
Fax: 212.326.8567

Russ Berrie Medical Science Pavilion
1150 St Nicholas Avenue, Room 318B
New York, NY 10032
Tel:
Fax: